Variação genética para os caracteres fisiológicos, bioquímicos e nutricionais em sementes de uma população base de Myracrodruon urundeuva procedente de Aquidauana-MS

Pós-graduação em Agronomia - FEIS

Levantamento florístico e colonização micorrízica em dois remanescentes de cerrado típico e em plantas ruderais no município de Três Lagoas-MS

Pós-graduação em Agronomia - FEIS

Dinâmica das comunidades de aves no mosaico de hábitats do Pantanal do Rio Negro, MS

Pós-graduação em Ciências Biológicas (Zoologia) - IBB

Estimativa da diversidade genética de Queixadas (Tayassu pecari) da região do Taboco (Corguinho, MS)

The Brazilian fauna has been constantly threatened by deforestation and forest fragmentation. As a result, many populations become isolated and small which negatively impacts their genetic diversity, putting them at a higher risk of extinction than large and stable populations. The aim of this work was to estimate the genetic diversity of white-lipped peccaries (Tayassu pecari) in the region of Taboco (Corguinho, MS), a fragmented area; and to compare these estimates with that obtained previously for two populations from Brazilian Pantanal, which is considered a relatively well-preserved biome and where the species is not threatened. A total of 18 blood and 72 hair samples of white-lipped peccaries had their DNA extracted and amplified for five polymorphic microsatellite loci. With the individuals identified, genetic diversity indicators (such as number of alleles, allelic richness, expected end and observed) and the inbreeding coefficient FIS were calculated. In addition, to verify if the population suffered a recent population bottleneck, we used the tests implemented in the program Bottleneck. The population of Taboco showed no evidence of recent population bottleneck (p > 0.05) or inbreeding (FIS = 0.008; p > 0.022). In addition, the levels of genetic diversity in this population (mean number of alleles = 2.60; mean allelic richness = 2.56 mean observed and expected heterozygosities = 0.45 and 0.47, respectively) were statistically similar to those found previously for the two populations from Pantanal (p > 0,05); although the region of Taboco is more impacted than the Pantanal. Even though we showed no evidence of loss of genetic diversity, it does not mean that the population is not suffering with fragmentation; but that there was not sufficient time to evidence the genetic changes. In addition, may be occurring gene flow with populations of nearby fragments, which is maintaining... (Complete abstract click electronic access below)

'Diabetology & Metabolic Syndrome: providing an open access future for diabetes research'

Diabetology & Metabolic Syndrome (D&MS), the official journal of the Brazilian Diabetes Society (SBD), is a new open access, peer reviewed journal publishing research on all aspects of the pathophysiology of diabetes and metabolic syndrome. With the many ongoing and upcoming challenges for diabetes diagnosis, treatment and care, a dedicated journal providing unrestricted access for researchers and health care professionals working in the field of diabetes is needed. Diabetology & Metabolic Syndrome aims to fulfil this need.

THE HISTONE DEACETYLASE INHIBITOR, MS-275, SENSITIZES METASTATIC OSTEOSARCOMA TO FASL-INDUCED CELL DEATH: A ROLE FOR C-FLIP

The purpose of this study was to determine the effects of the histone deacetylase inhibitor, MS-275, on the Fas signaling pathway and susceptibility of osteosarcoma (OS) to Fas ligand (FasL)-induced cell death. OS metastasizes almost exclusively to the lungs. We have shown that Fas expression in OS cells is inversely correlated with their metastatic potential. Fas+ cells are rapidly eliminated when they enter the lungs via interaction with FasL, which is constitutively expressed in the lungs. Fas- OS cells escape this FasL-induced apoptosis and survive in the lung microenvironment. Moreover, upregulation of Fas in established OS lung metastases results in tumor regression. Therefore, agents that upregulate Fas expression or activate the Fas signaling pathway may have therapeutic potential. Treatment of Fas- metastatic OS cell lines with 2 μM MS-275 sensitized cells to FasL-induced cell death in vitro. We found that MS-275 did not alter the expression of Fas on the cell surface; rather it resulted in increased levels of Fas within the membrane lipid rafts, as demonstrated by an increase in Fas expression in detergent insoluble lipid raft fractions. We further demonstrated that following MS-275 treatment, Fas colocalized with GM1+ lipid rafts and that there was a decrease in c-FLIP (cellular FLICE-inhibitory protein) mRNA and protein. Downregulation of c-FLIP correlated with caspase activation and apoptosis induction. Transfection of cells with shRNA to c-FLIP also resulted in the localization of Fas to lipid rafts. These studies indicate that MS-275 sensitizes OS cells to FasL by upregulating the expression of Fas in membrane lipid rafts, which correlated with the downregulation of c-FLIP. Treatment of nu/nu-mice with established OS lung metastases with oral MS-275 resulted in increased apoptosis, a significant inhibition of c-FLIP expression in tumors and tumor regression. Histopathological examination of mice showed no significant organ toxicity. Overall, these results suggest that the mechanism by which MS-275 sensitizes OS cells and lung metastases to FasL-induced cell death may be by a reduction in the expression of c-FLIP.